Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
PYC Therapeutics Ltd
PYCCurrent price
0.19 AUD
+0.005 AUD (+2.70%)
Last closed
0.19 AUD
Company
pyctx.com
ISIN
AU000000PYC7
Sector
Healthcare
Industry
Biotechnology
Exchange
Australian Securities Exchange
Capitalization
923 727 983 AUD
Yield for 12 month
+170.79 %
1Y
3Y
5Y
10Y
15Y
PYC
PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia. The company offers VP-001, a drug program which is Phase 1 clinical trial for the treatment of retinitis pigmentosa type 11; PYC-001, a drug candidate for the treatment of blinding eye disease; PYC-002 a drug program for the treatment of a severe neurodevelopmental disorder; and PYC-003, which is indicated to treat autosomal dominant polycystic kidney disease. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to support drug discovery and development efforts in the field of neurodegenerative disorders. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia. Address: Harry Perkins Inst. of Medical Research, Nedlands, WA, Australia, 6009
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.51 AUDP/E ratio
–Dividend Yield
–Current Year
+22 394 909 AUD
Last Year
+16 046 722 AUD
Current Quarter
+13 352 097 AUD
Last Quarter
+9 042 812 AUD
Current Year
+21 310 901 AUD
Last Year
+15 151 257 AUD
Current Quarter
+12 609 628 AUD
Last Quarter
+8 701 274 AUD
Key Figures PYC
1 year
3 years
5 years
10 years
EBITDA
-38 697 446 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-37.83 %
PEG Ratio
–
Return On Equity TTM
-69.61 %
Wall Street Target Price
0.51 AUD
Revenue TTM
22 394 909 AUD
Book Value
0.017 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
6.6 %
Dividend Yield
–
Gross Profit TTM
16 046 721 AUD
Earnings per share
-0.01 AUD
Diluted Eps TTM
-0.01 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-171.02 %
Dividend Analytics PYC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PYC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
15.11.2024
Dividend Date
–
Stock Valuation PYC
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
41.2472
Enterprise Value EBITDA
-8.4071
Price Book MRQ
11.5934
Financials PYC
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators PYC
For 52 weeks
0.069 AUD
0.21 AUD
50 Day MA
0.17 AUD
Shares Short Prior Month
–
200 Day MA
0.12 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart